Pacira Germany GmbH

General information
Pacira Germany GmbH
Harburger Schlossstr. 6-12
21079 Hamburg, Hamburg
Germany

Contact person: Kilian Guse, Vice President Genetic Medicine Platforms
Company main phone: +49 (40) 999993026
Website:  https://www.pacira.com/
Year founded:2012
Source of foundation:Independent foundation
Corporate description / mission:
Pacira Germany is a subsidiary of Pacira BioSciences, Inc. At their Brandenburg (Luckenwalde) R&D facility, Pacira develops genetic medicines using the proprietary high-capacity adenovirus (HCAd) platform initially established by GQ Bio. This technology overcomes historical genetic medicine bottlenecks by enabling large/multiple gene transfer, highly efficient transduction, and large-scale manufacturing.
State of ownership: Subsidiary
Headquarters: HQ: No
Remarks on ownership / listings
Pacira Germany GmbH is a wholly-owned subsidiary of Pacira BioSciences, Inc

Formerly known as GQ Bio Therapeutics GmbH and GeneQuine Biotherapeutics GmbH
Categorization
Sector:
  • Biotechnology - Therapeutics and Diagnostics
Subsector:
  • Gene therapy
Primary therapeutic areas:
  • Musculoskeletal system and connective tissue / Orthopedics
Business model:
  • R&D
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Summary Products / Services / Technologies
Number of Biotech Products
Phase II:1
Description of products:
PCRX-201 (enekinragene inzadenovec)
Technology used:
HCAd Vector Platform
© 2026 Biotechgate by Venture Valuation
X